JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109. A total of 180 filers reported holding JUNO THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 0.57 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $494,000 | +30.7% | 10,841 | +27.3% | 0.00% | 0.0% |
| Q3 2017 | $378,000 | +48.8% | 8,518 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $254,000 | +34.4% | 8,518 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $189,000 | +112.4% | 8,518 | +80.5% | 0.00% | – |
| Q4 2016 | $89,000 | -68.4% | 4,718 | -50.0% | 0.00% | – |
| Q3 2016 | $282,000 | +55.8% | 9,436 | +100.0% | 0.00% | -100.0% |
| Q2 2016 | $181,000 | +1.1% | 4,718 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $179,000 | -13.5% | 4,718 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $207,000 | – | 4,718 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|